MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MATTHEWS, E. K.
Right arrow Articles by NORDMANN, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MATTHEWS, E. K.
Right arrow Articles by NORDMANN, J. J.

Molecular Pharmacology, Vol 12, 778-788, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

The Synaptic Vesicle: Calcium Ion Binding to the Vesicle Membrane and Its Modification by Drug Action

E. K. MATTHEWS 1 and J. J. NORDMANN 1

1 Department of Pharmacology, University of Cambridge, Cambridge, England

The ionogenic nature of the synaptic vesicle surface and its calcium adsorption characteristics have been investigated by microelectrophoretic measurements on vesicles isolated from the guinea pig cerebral cortex. The electrophoretic mobility of synaptic vesicles determined in 0.16 M KCl was -1.31 µm sec-1 cm V-1, corresponding to a surface zgr potential of -18.2 mV and surface charge density of 5451 esu cm-2. Whereas the monovalent cation species of the suspending medium had little effect upon the electrokinetic properties of synaptic vesicles, addition of Ca2+, 1-10 mM, markedly decreased the surface charge. From the monomolecular adsorption isotherm the number of Ca2+ binding sites was found to be 4.17 x 1012 cm-2, with an electrochemical free energy of calcium ion adsorption, DgrGCa2+, of -5.00 kcal mole-1, increasing to -5.64 kcal mole-1 at low (0.02) ionic strength. Adenine and pyridine nucleotides (1 mM) were without effect on synaptic vesicle mobility. In contrast, the neuroactive agents trifluoperazine, benzyl alcohol, and amylobarbitone decreased the surface charge of the synaptic vesicle per se, irrespective of any effect on Ca2+ binding. These results are discussed in relation to the ionogenic properties of the synaptic vesicle surface and the molecular mechanism of drug action on the neunotransmitter release process.

Note:
ACKNOWLEDGMENTS We are indebted to Dr. P. M. Dean and Mrs. G. A. Currell for their expert help in this study.

Submitted on December 29, 1975
Accepted on April 19, 1976







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics